Question 1

What are the key details for the project “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)”?

Accepted Answer

The project “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)” is an infrastructure initiative in the Bridge sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)”?

Accepted Answer

The status recorded for “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)”?

Accepted Answer

Taiyo maps the stakeholders of “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

Where can I verify the source and access all details for “Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=63714). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	The National Institute of Nursing Research (NINR) seeks to stimulate research that will link basic genomic discovery to the prevention and alleviation of symptoms in patients suffering from chronic disorders. Research grant applications are requested to study 1) the role of genomic variants in the observed inter-individual variation in the onset, sensitivity, duration, and severity of symptoms and/or responses to therapies designed to prevent, alleviate, or eliminate symptoms, and 2) the role of non-genomic influence(s) that may potentially moderate the effects of genomic variants in the manifestation of symptoms and/ or response to treatment. It is anticipated that the findings from this research will expand the body of knowledge needed to identify individuals at the highest risk for developing severe symptoms and to inform the search for customized therapeutics and interventions tailored to an individuals genomic profile.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)

Project Information FAQ

Project Information